# \[e-drug\] Access to Medicines in Southern Africa

**URL:** https://talk.edrugplus.org/t/e-drug-access-to-medicines-in-southern-africa/33772
**Category:** e-drug
**Created:** [May 11, 2010, 6:21am UTC](https://talk.edrugplus.org/t/e-drug-access-to-medicines-in-southern-africa/33772 "2010-05-11T06:21:44Z")
**Posts on this page:** 2
**Page:** 1

<div class="post-metadata">

### Author: ![Adi\_Eyal](https://avatars.discourse-cdn.com/v4/letter/a/8491ac/32.png) [@Adi\_Eyal](https://talk.edrugplus.org/u/Adi_Eyal)
#### Post date: [May 11, 2010, 6:21am UTC](https://talk.edrugplus.org/t/e-drug-access-to-medicines-in-southern-africa/33772/1 "2010-05-11T06:21:44Z")

</div>

E-DRUG: Access to Medicines in Southern Africa  
---------------------------------------  
[The availability of essential medicines also depends on good management including appropriate use, record keeping, quantification and forecasting for efficient procurement, distribution and stock maintenance. Moderator]

Dear E-Druggers

I am involved in the Southern African Regional Programme on Access to  
Medicines (SARPAM) which has the overall goal of reducing the disease  
burden in Southern Africa by increasing access to affordable essential  
medicines. The programme's purpose is to strengthen the capacity  
across the SADC region in order to improve the availability,  
affordability and quality of essential medicines and diagnostics.

As one of the outputs of this programme, we are planning the  
development of an Information Hub which will provide open access to  
medicine pricing data, as well as information relating to medicine  
regulation, availability and affordability. We hope to utilise data  
from existing databases as well as data gathered within the context of  
SARPAM. We are looking for suggestions as to what information needs  
currently exist in order to further our aim of alleviating the  
information assymmetries that exist within this region.

Our target audience is all stakeholders involved in the pharmaceutical  
supply chain including, manufacturers, procurement agencies,  
regulators, policy makers, researchers and end consumers. We would be  
very happy to receive suggestions from this mailing list's members,  
regarding potential information needs within the region, available  
data sources or interested parties.

Many thanks

Adi Eyal  
Data Manager: SARPAM  
tel: +27 21 685 1846  
mobile: +27 78 014 2469  
skype: adieyalcas  
Adi Eyal \<adi@sarpam.net\>

---

<div class="post-metadata">

### Author: ![Sefali](https://avatars.discourse-cdn.com/v4/letter/s/f19dbf/32.png) [@Sefali](https://talk.edrugplus.org/u/Sefali)
#### Post date: [May 12, 2010, 6:24am UTC](https://talk.edrugplus.org/t/e-drug-access-to-medicines-in-southern-africa/33772/2 "2010-05-12T06:24:33Z")

</div>

E-DRUG: Access to Medicines in Southern Africa (2)  
------------------------------------------

For Countries that are challenged in terms of Human Resource to effectively  
determine the quality of the Pharmaceutical Sources in Asia, which are very  
competitive in terms of pricing, it will be very good if we can have a data  
base of the registration status of the products from the Suppliers in Asia  
for distribution within the Sadc Countries. So that when we issue out our tender documents we  
can just indicate as an eligibility criteria that the product must be on the  
"SADC Pre-qualified List of Essential Medicines".

I am talking of something more or less similar to WHO-Prequalification Project for HIV/AIDs products.  
Secondly, information sharing Hub will be very Essential especially in the  
areas of BAD PRACTICEs so that if Supplier A defaults in of the SADC Member  
Country, that Supplier A should know that chances of getting "ACTION" from  
all the SADC countries is there.

MR Sefali  
General Manager of NDSO  
Lesotho  
"Sefali" \<gm@ndso.org.ls\>
